PVM
HCAT icon

Palogic Value Management’s Health Catalyst HCAT Stock Holding History

Palogic Value Management’s Portfolio HCAT Stock Details HCAT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$3.68M Buy
2,896,600
+1,626,559
+128% +$3.06M 1.55% 15
2025
Q4 		$3.04M Buy
1,270,041
+178,222
+16% +$487K 1.27% 19
2025
Q3 		$3.11M Buy
1,091,819
+361,719
+50% +$1.24M 1.25% 19
2025
Q2 		$2.75M Buy
730,100
+80,100
+12% +$315K 1.12% 25
2025
Q1 		$2.94M Buy
650,000
+330,000
+103% +$1.75M 1.27% 23
2024
Q4 		$2.26M Buy
+320,000
New +$2.55M 0.86% 36

Other funds holding HCAT

FLAM
First Light Asset Management Edina, Minnesota $1.12B AUM 114.45% 1-Year Est. Return
CF
CDC Financial Chicago, Illinois $157M AUM
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
WCA
Whetstone Capital Advisors Shawnee Mission, Kansas $288M AUM 44.06% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Impax Asset Management Group
Impax Asset Management Group London, United Kingdom $14.3B AUM 19.8% 1-Year Est. Return
NI
Nepsis Inc Minneapolis, Minnesota $295M AUM 35.44% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

Palogic Value Management's HCAT Position: Q1 2026 in Review

Palogic Value Management increased its Health Catalyst (HCAT) stake by 128% in Q1 2026, buying an estimated $3.06M and bringing the position to 2,896,600 shares worth $3.68M. The position accounts for 1.55% of the portfolio, ranked #15.

Palogic Value Management first reported a position in HCAT in Q4 2024 and has held it in 6 quarters since. 130 funds tracked by Wall St. Rank hold HCAT as of Q1 2026.

  • Palogic Value Management held 2,896,600 shares of Health Catalyst worth $3.68M as of Q1 2026.
  • Palogic Value Management bought 1,626,559 Health Catalyst shares in Q1 2026, an estimated $3.06M.
  • Health Catalyst made up 1.55% of Palogic Value Management's portfolio in Q1 2026, its #15 holding.
  • Palogic Value Management first reported a position in Health Catalyst in Q4 2024 and has held it in 6 quarters since.
  • 130 funds tracked by Wall St. Rank held Health Catalyst as of Q1 2026.

Based on Palogic Value Management's 13F filing for Q1 2026, filed 15 May 2026.